Thermoacoustic Method for Estimating Liver Fat Fraction

Part of paid clinical trials in Ann Arbor, Michigan.

Sponsor
Endra Lifesciences
Study ID
NCT07321925
Status
Recruiting
Apply to this trial

Conditions

  • Fatty Liver Disease, Nonalcoholic
  • MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Thermoacoustic Enhanced Ultrasound — DEVICE
    a novel Thermoacoustic Enhanced imaging device

Study Details

The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to create a more accessible device to measure liver fat as it is an indicator for overall health and metabolic diseases.

Key Dates

Start date
Aug 15, 2025
Status verified
Dec 2025
Primary completion
Oct 30, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
49 participants (estimated)

Primary Outcome Measure

Correlation between Thermoacoustic Fat Fraction (TAFF) and the MRI-PDFF [ Time Frame: From enrollment until the statistical analysis is reviewed, typically 2 weeks after last MRI data is received. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
ENDRA Life SciencesAnn ArborMichigan48105
Ava Ohlgren
[email protected]
734-210-0129
Chris Bull
[email protected]
734-210-0129

Find similar trials in Ann Arbor, MI

By research site
ENDRA Life Sciences· Ann Arbor, MI

Related Studies